Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Redesign Science logo — Biology Simulated

Redesign Science

Biology Simulated

Founded 2017 United States New York, United States 9 employees Seed Biotechnology, Health Care +1

General Information

Company Name Redesign Science
Founded Year 2017
Location United States New York, United States
Employees 9
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Redesign Science. To contact Redesign Science, visit redesignscience.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Redesign Science compare?

A PDF of Redesign Science and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Redesign Science soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Redesign Science

Redesign Science is a biotech startup founded in 2017 with a slogan "Biology Simulated". The company operates at the intersection of physics-based molecular simulation and deep learning to develop generative AI for drug discovery. Their focus is on creating first-in-class Protein Interaction Modulators targeting validated targets associated with the progression of multiple oncogenic and inflammatory diseases.

The startup operates in the industries of Biotechnology, Health Care, and Pharmaceutical and is headquartered in the United States.

Redesign Science has not disclosed its last investment or the participating investors.

No funding data available for Redesign Science yet.

Redesign Science Alternatives & Competitors

View All Alternatives
Redesign Science vs
Biotheryx, Inc.
Biotheryx, Inc. United States

Degrading proteins. Saving lives. Building the leader in next-generation targeted protein degradatio...

Series E
25 employees
Biotechnology, Health Care
Redesign Science vs
Ventus Therapeutics
Ventus Therapeutics United States

Pioneering a unique approach to structure-based drug discovery. Located in Waltham, MA and Montreal,...

Grant
55 employees
Biotechnology, Health Care
Redesign Science vs
Alector
Alector United States

We are on a mission to make brain disorders history.

IPO
141 employees
Biotechnology, Health Care
View all alternatives

FAQ About Redesign Science

Biology Simulated
Redesign Science was founded in 2017.
Redesign Science is headquartered in New York, United States.
Redesign Science operates in Biotechnology, Health Care and Pharmaceutical.
Redesign Science has approximately 9 employees.
Top alternatives and competitors to Redesign Science include Biotheryx, Inc., Ventus Therapeutics, Alector, AmyPore, Frontier Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Redesign Science and Biotheryx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Redesign Science, https://bouncewatch.com/company/redesign-science, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes